The Pill Has Prevented 200,000 Endometrial Cancer Cases in the Last Decade Alone
Experts have known that women who take birth-control pills have a lower risk of endometrial cancer, and a new study offers insight into how long the protective effect lasts and how many cancer cases have likely been prevented.Source: New York Magazine
Five Yale researchers awarded grants to study women’s reproductive cancers
Five researchers from the Yale School of Medicine have received grants from Discovery to Cure, a program at the Department of Obstetrics, Gynecology, and Reproductive Sciences that advances the prevention, early detection, and treatment of women’s reproductive cancers such as ovarian, uterine, cervical, vaginal, and vulvar cancers.
Expert Opinion: FDA considers drug known as the ‘female Viagra’
Expert Opinion is a new series where Yale experts give their opinion on medical-themed stories in the news. In this edition, OBGYN Mary Jane Minkin explains how flibanserin, dubbed the 'female viagra' in the press, works and why the name might be misleading.Source: YouTube/YaleMedicine
WHRY and Elevate Expand Help for Women and Families in Need
Recognizing the urgent need to ensure the health of women in our communities, Women’s Health Research at Yale and Elevate, the university’s health policy lab, are collaborating to deploy interventions grounded in the latest and most reliable research directly to women and families.
Research Begun by WHRY Continues to Show Possible Pathway to Derail Dementia
Research is revealing the mechanisms that underlie the role of estradiol in memory so that next generation treatments for Alzheimer's disease and other dementias can specifically target these mechanisms and avoid the potential for negative side effects of systemic estrogen therapy.